T Ohnuma
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
- HER2/EGFR in Cancer Research
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 17
- Cancer Treatment and Pharmacology 10
- Drug Transport and Resistance Mechanisms 3
-
- Cancer therapeutics and mechanisms 4
- Glycosylation and Glycoproteins Research 2
- Co-authors
- D L Trump (1 shared paper)B Leyland-Jones (1 shared paper)R. Gralla (1 shared paper)Daniel D. Von Hoff (1 shared paper)R B Weiss (1 shared paper)David A. Van Echo (1 shared paper)James R. Baker (1 shared paper)Peter H. Wiernik (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)British Journal of Cancer (3 papers)Recent results in cancer research (2 papers)Cancer (2 papers)Molecular Pharmacology (1 paper)
- Partner nations
- United StatesJapanFrance
In The Last Decade
T Ohnuma
39 papers receiving 1.7k citations
T Ohnuma's Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 716
- Biomaterials 346
- Dermatology 128
- Pharmaceutical Science 85
- Pharmacology 141
Countries citing papers authored by T Ohnuma
This map shows the geographic impact of T Ohnuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Ohnuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Ohnuma more than expected).
Fields of papers citing papers by T Ohnuma
This network shows the impact of papers produced by T Ohnuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Ohnuma. The network helps show where T Ohnuma may publish in the future.
Co-authors
The 25 scholars most cited alongside T Ohnuma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hypersensitivity reactions from taxol. Hit paper breakdown → | 1990 | 996 |
| 2 | Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme. | 1994 | 96 |
| 3 | 1973 | 86 | |
| 4 | 1981 | 75 | |
| 5 | 1985 | 55 | |
| 6 | Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate. | 1989 | 47 |
| 7 | 1994 | 43 | |
| 8 | 1986 | 39 | |
| 9 | 1980 | 35 | |
| 10 | 1979 | 33 | |
| 11 | Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate. | 1991 | 31 |
| 12 | Phase I study of indicine N-oxide in patients with advanced cancer. | 1982 | 23 |
| 13 | Hepatic catalase activity in advanced human cancer. | 1966 | 22 |
| 14 | 1988 | 20 | |
| 15 | 1985 | 19 | |
| 16 | Initial clinical study with N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with advanced cancer. | 1981 | 19 |
| 17 | Phase I study of acivicin in patients with advanced cancer. | 1983 | 17 |
| 18 | 1988 | 15 | |
| 19 | Phase I study of weekly maytansine given by iv bolus or 24-hour infusion. | 1980 | 14 |
| 20 | 2006 | 13 |
About T Ohnuma
T Ohnuma is a scholar working on Oncology, Molecular Biology, Public Health, Environmental and Occupational Health, Dermatology and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Acute Lymphoblastic Leukemia research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Chemotherapy-related skin toxicity (4 papers), Cancer therapeutics and mechanisms (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Oncology (716 citations), Biomaterials (346 citations), Dermatology (128 citations), Pharmaceutical Science (85 citations) and Pharmacology (141 citations). T Ohnuma has collaborated with scholars based in United States, Japan and France. Frequent co-authors include D L Trump, B Leyland-Jones, R. Gralla, Daniel D. Von Hoff, R B Weiss, David A. Van Echo, James R. Baker, Peter H. Wiernik, Ross C. Donehower and J F Holland. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Recent results in cancer research, Cancer and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.